✦ LIBER ✦

Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB–IV

✍ Scribed by Werner Meier; Andreas du Bois; Jörn Rau; Martina Gropp-Meier; Klaus Baumann; Jens Huober; Kerstin Wollschlaeger; Rolf Kreienberg; Ulrich Canzler; Barbara Schmalfeldt; Pauline Wimberger; Barbara Richter; Willibald Schröder; Antje Belau; Anne Stähle; Alexander Burges; Jalid Sehouli

Book ID: 113964178
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 336 KB
Volume: 126
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.04.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line treatment of ovarian cancer F

First-line treatment of ovarian cancer FIGO stages IIb–IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

✍ G. B. Kristensen; I. Vergote; G. Stuart; J. M. Del Campo; J. Kaern; A. B. Lopez; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Epirubicin/paclitaxel/carboplatin (TEC)

Epirubicin/paclitaxel/carboplatin (TEC) vs paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer FIGO stages IIB–IV. Results of a randomized AGO-GINECO GCIG Intergroup phase III trial

✍ E. PUJADE-LAURAINE; A. du BOIS; A. GOUPIL; J. ROCHON; V. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

Epirubicin/paclitaxel/carboplatin (TEC)

Epirubicin/paclitaxel/carboplatin (TEC) vs paclitaxel/carboplatin in first line treatment of ovarian carcinoma figo stage II b-IV. Preliminary results. A GINECO randomized trial

✍ Weber, B.; Kuhn, W.; Goupil, A.; Blohmer, J.; Guichard, F.; Quaas, J.; Lucas, V. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB

A randomized phase II study of paclitaxe

A randomized phase II study of paclitaxel with carboplatin ± amifostine as first line treatment in advanced ovarian carcinoma

✍ F.Y.F.L De Vos; A.M.E. Bos; M. Schaapveld; C.A.M. de Swart; H. de Graaf; A.G.J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Phase II Trial of Topotecan, Carboplatin

Phase II Trial of Topotecan, Carboplatin, and Paclitaxel as Front-Line Therapy in Suboptimal Advanced Epithelial Ovarian Cancer

✍ G. Bolis; G. Scarfone; A. Villa; F. Parazzini 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 29 KB

36 Paclitaxel/Carboplatin(TC) vs Paclita

36 Paclitaxel/Carboplatin(TC) vs Paclitaxel/Carboplatin sequentially followed by Topotecan (TC-Top) in first-line treatment of ovarian cancer Flgo stages IIB – IV interim results of a gynaecologic cancer intergroup phase III trial of the Ago ovarian cancer study group and Gineco

✍ E. Pujade-Lauraine; J. Pfisterer; A. Lortholary; R. Kimmig; B. Weber; A. du Bois 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB